A new synthetic route of 27469-61-0

The article 《Development and validation of an in silico P450 profiler based on pharmacophore models》 also mentions many details about this compound(27469-61-0)HPLC of Formula: 27469-61-0, you can pay attention to it, because details determine success or failure

Heterocyclic compounds can be divided into two categories: alicyclic heterocycles and aromatic heterocycles. Compounds whose heterocycles in the molecular skeleton cannot reflect aromaticity are called alicyclic heterocyclic compounds. Compound: 27469-61-0, is researched, Molecular C17H18Cl2N2, about Development and validation of an in silico P450 profiler based on pharmacophore models, the main research direction is Cytochrome P450 inhibitor pharmacophore model enzyme kinetics.HPLC of Formula: 27469-61-0.

In today’s drug discovery process, the very early consideration of ADME properties is aimed at a reduction of drug candidate drop out rate in later development stages. A part from in vitro testing, in silico methods are evaluated as complementary screening tools for compounds with unfavorable ADME attributes. Especially members of the cytochrome P 450 (P 450) enzyme superfamily. e.g. P 450 1A2, P 450 2C9, P 450 2C19, P 450 2D6, and P 450 3A4, contribute to xenobiotic metabolism, and compound interaction with one of these enzymes is therefore critically evaluated. Pharmacophore models are widely used to identify common features amongst ligands for any target. In this study, both structure-based and ligand-based models for prominent drug-metabolizing members of the P 450 family were generated employing the software packages LigandScout and Catalyst. Essential chem. ligand features for substrate and inhibitor activity for all five P 450 enzymes investigated were determined and analyzed. Finally, a collection of 11 pharmacophores for substrates and inhibitors was evaluated as an in silico P 450 profiling tool that could be used for early ADME estimation of new chem. entities.

The article 《Development and validation of an in silico P450 profiler based on pharmacophore models》 also mentions many details about this compound(27469-61-0)HPLC of Formula: 27469-61-0, you can pay attention to it, because details determine success or failure

Reference:
Tetrahydropyran – Wikipedia,
Tetrahydropyran – an overview | ScienceDirect Topics